Volume 11, Number 8—August 2005
Dispatch
Cost-Benefit of Stockpiling Drugs for Influenza Pandemic
Table A5
Relative risk (RR) and 95% confidence interval (95% CI) for influenza infection and protective efficacy of individual trials with estimate of preexposure (seasonal) prophylaxis
Trial | Drug | RR (95% CI) | Protective efficacy (%) | p value for heterogeneity |
---|---|---|---|---|
Hayden et al. (11) | Oseltamivir | 0.26 (0.13–0.50) | 74 | |
Monto et al. (15) | Zanamivir | 0.32 (0.17–0.63) | 68 | |
Overall | 0.29 (0.20–0.43) | 71 | 0.643 |